Matching slides 78,129
Current window 7,681-7,710
Pages 2,605
Rows per page 30
Component: Chartclear collectionreset all

Component

7,681-7,710 of 78,129

filter-aware
11
Includes three distinct data panels: bar chart for viscosity, line charts for stability (SEC and IEX), and a dose-response curve for potency.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle3 hits
25
The slide uses a consistent color scheme where the most recent quarter (3Q23) is highlighted in a darker blue.FGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · Financials3 hits
13
The slide uses a before-after comparison structure for three specific patient cases (15B-01, 15B-15, 15B-17).Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · Traction3 hits
06
The slide uses a combination of bar charts for absolute dollar values and line charts for percentage margins.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction3 hits
07
Includes footnotes detailing reconciliation and definitions.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Loop · Cost Of Inaction3 hits
16
Includes comparative data points for transduction efficiency and experimental data for tonic signaling and anti-exhaustion.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & Proof3 hits
36
Includes a complex biological pathway diagram and three supporting charts (penetration depth, accumulation over time, and apoptosis efficacy).Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps3 hits
47
Slide contains three distinct data charts comparing IMX-110 against standard treatments in mouse models.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps3 hits
50
The slide compares two cohorts: Soft Tissue Sarcoma and Non-Sarcoma Cancers, using line charts for longitudinal change and bar charts for best response.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps3 hits
54
Includes comparative size illustration of IMX-111 vs IgG antibody, and survival curve data.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps3 hits
25
The slide uses donut charts to represent percentage splits of remuneration components and bar charts for historical financial data.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Future Vision (Gain)3 hits
16
Data presented as mean +/- S.E. of mean; N=7 patients.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain3 hits
24
Includes box plots for gene expression and a tumor volume growth curve over time.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · Action3 hits
31
Includes longitudinal line charts for blood mRNA levels and a bar chart/enrichment plot for tumor response.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · Action3 hits
35
Includes three dose-response curves and a comparative table of clinical stage and potency metrics.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · Action3 hits
18
The slide uses three charts: a bar chart for food intake and two line charts for body weight loss (BWL) in different mouse models.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · Product3 hits
19
The slide highlights that DA-1726 achieves weight loss through mechanisms other than just food reduction, as evidenced by higher food intake compared to Tirzepatide.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · Product3 hits
11
The slide presents preclinical efficacy data for NXP800 in specific genetic subtypes of endometrial cancer.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Market Size3 hits
30
The slide uses three line charts to provide a snapshot of the current financial environment.SoftBank | Results Presentation Deck | 100 slides · SoftBank
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction3 hits
41
The slide highlights currency matching as a risk management strategy for SoftBank Group.SoftBank | Results Presentation Deck | 100 slides · SoftBank
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction3 hits
107
The slide uses a gradient bar chart style to represent financial values.SoftBank | Results Presentation Deck | 130 slides · SoftBank
Conference presentation Investor relations 3 hits
05
Data sourced from Bloomberg; indices indexed to 100 as of Dec 31, 2021.SoftBank | Results Presentation Deck | 43 slides · SoftBank
Conference presentation Investor relations Beat · Attention3 hits
16
The slide uses three pie charts to show the currency distribution of assets and liabilities.SoftBank | Results Presentation Deck | 43 slides · SoftBank
Conference presentation Investor relations Beat · Satisfaction3 hits
28
The slide uses pie charts to illustrate currency concentration (USD vs JPY vs EUR) across three financial categories.SoftBank | Results Presentation Deck | 56 slides · SoftBank
Conference presentation Investor relations Beat · Solution3 hits
35
The slide highlights a divergence between strong internal financial metrics (NAV, LTV) and external credit ratings (S&P).SoftBank | Results Presentation Deck | 56 slides · SoftBank
Conference presentation Investor relations Beat · Solution3 hits
03
Includes footnotes regarding revenue composition, session definitions, and non-GAAP reconciliation.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · AttentionLoop · Logic Chain3 hits
07
The slide uses a grouped bar chart format to compare UBS and Credit Suisse performance metrics over five quarters.UBS | Results Presentation Deck | 31 slides · UBS
Conference presentation Investor relations Beat · Need3 hits
22
Includes waterfall-style bridge annotations for RWA and LRD changes.UBS | Results Presentation Deck | 31 slides · UBS
Conference presentation Investor relations Beat · ActionLoop · Zoom In3 hits
29
Includes two waterfall charts and one stacked bar chart.UBS | Results Presentation Deck | 31 slides · UBS
Conference presentation Investor relations Beat · Action3 hits
09
The slide uses a pyramid-like structure to show the group's composition.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Need3 hits